Reporting of retrospective registration in clinical trial publications: a cross-sectional study of German trials

被引:7
|
作者
Haslberger, Martin [1 ]
Gestrich, Stefanie [1 ]
Strech, Daniel [1 ]
机构
[1] Berlin Inst Hlth Charite, QUEST Ctr Responsible Res, Berlin, Germany
来源
BMJ OPEN | 2023年 / 13卷 / 04期
关键词
Medical ethics; Statistics & research methods; Clinical trials; STATEMENT;
D O I
10.1136/bmjopen-2022-069553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Prospective registration has been widely implemented and accepted as a best practice in clinical research, but retrospective registration is still commonly found. We assessed to what extent retrospective registration is reported transparently in journal publications and investigated factors associated with transparent reporting. Design We used a dataset of trials registered in ClinicalTrials.gov or Deutsches Register Klinischer Studien, with a German University Medical Center as the lead centre, completed in 2009-2017, and with a corresponding peer-reviewed results publication. We extracted all registration statements from results publications of retrospectively registered trials and assessed whether they mention or justify the retrospective registration. We analysed associations of retrospective registration and reporting thereof with registration number reporting, International Committee of Medical Journal Editors (ICMJE) membership/-following and industry sponsorship using chi(2) or Fisher exact test. Results In the dataset of 1927 trials with a corresponding results publication, 956 (53.7%) were retrospectively registered. Of those, 2.2% (21) explicitly report the retrospective registration in the abstract and 3.5% (33) in the full text. In 2.1% (20) of publications, authors provide an explanation for the retrospective registration in the full text. Registration numbers were significantly underreported in abstracts of retrospectively registered trials compared with prospectively registered trials. Publications in ICMJE member journals did not have statistically significantly higher rates of both prospective registration and disclosure of retrospective registration, and publications in journals claiming to follow ICMJE recommendations showed statistically significantly lower rates compared with non-ICMJE-following journals. Industry sponsorship of trials was significantly associated with higher rates of prospective registration, but not with transparent registration reporting. Conclusions Contrary to ICMJE guidance, retrospective registration is disclosed and explained only in a small number of retrospectively registered studies. Disclosure of the retrospective nature of the registration would require a brief statement in the manuscript and could be easily implemented by journals.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Endorsement of reporting guidelines and clinical trial registration across Scopus-indexed rheumatology journals: a cross-sectional analysis
    Jelinek, Trevon
    Shumard, Alexandra
    Modi, Jay
    Smith, Caleb
    Nees, Danya
    Hughes, Griffin
    Vassar, Matt
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (05) : 909 - 917
  • [32] Endorsement of reporting guidelines and clinical trial registration across Scopus-indexed rheumatology journals: a cross-sectional analysis
    Trevon Jelinek
    Alexandra Shumard
    Jay Modi
    Caleb Smith
    Danya Nees
    Griffin Hughes
    Matt Vassar
    Rheumatology International, 2024, 44 : 909 - 917
  • [33] Reporting Compliance of Stroke Trials: Cross-Sectional Analysis
    Malhotra, Konark
    Rayi, Appaji
    Khunger, Monica
    Thompson, Stephanie
    Liebeskind, David S.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (07): : 1472 - 1480
  • [34] Concordance between clinical trial data use request proposals and corresponding publications: A cross-sectional study
    Vazquez, Enrique
    Ross, Joseph S.
    Gross, Cary P.
    Childers, Karla
    Bamford, Stephen
    Ritchie, Jessica D.
    Waldstreicher, Joanne
    Krumholz, Harlan M.
    Wallach, Joshua D.
    CLINICAL TRIALS, 2024,
  • [35] Identifying trials run in India that are registered in other clinical trial registries: a cross-sectional study
    Borah, Rishima
    Samanta, Anwesha Dhal
    Mendiratta, Jaishree
    Mishra, Manish
    Saberwal, Gayatri
    BMC MEDICAL RESEARCH METHODOLOGY, 2024, 24 (01)
  • [36] Dissemination and outcome reporting bias in clinical malaria intervention trials: a cross-sectional analysis
    Pool, Lydia
    Ruiz del Portal Luyten, Claire
    van der Pluijm, Rob W.
    Soentjens, Patrick
    Hanscheid, Thomas
    Grobusch, Martin P.
    Visser, Benjamin J.
    MALARIA JOURNAL, 2024, 23 (01)
  • [37] Cost assessment in melanoma clinical trials: A cross-sectional study
    Goodman, Rachel S.
    Garner, Desmond C.
    Koester, Stefan
    Patrinely Jr, J. Randall
    Dewan, Anna K.
    Johnson, Douglas B.
    JAAD INTERNATIONAL, 2023, 12 : 139 - 141
  • [38] Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
    Miller, Jennifer E.
    Korn, David
    Ross, Joseph S.
    BMJ OPEN, 2015, 5 (11):
  • [39] Registration and reporting of clinical trials
    Khopkar, Uday
    Pande, Sushil
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2008, 74 (01): : 2 - 4
  • [40] Seamless trials in oncology: A cross-sectional analysis of characteristics and reporting
    Klas, Katarzyna
    Strzebonska, Karolina
    Buedo, Paola
    Wlodarczyk, Alicja
    Gordon, Samuel
    Kaszuba, Paulina
    Polak, Maciej
    Waligora, Marcin
    PLOS ONE, 2024, 19 (12):